Annet Aketoko Onzia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Annet Aketoko Onzia has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Matthew M. Hamill
Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland
7 shared publications Yukari C. Manabe
Johns Hopkins University School of Medicine, Baltimore, Maryland
6 shared publicationsJohan H. Melendez
Johns Hopkins University School of Medicine
5 shared publicationsRosalind Parkes-Ratanshi
Infectious Diseases Institute, Makerere University, Kampala, Uganda
4 shared publications- Rosalind Parkes-Ratanshi
Infectious Disease Institute, Makerere University, Kampala, Uganda
4 shared publications - Yukari Carol Manabe
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland
4 shared publications
Latest Publications
- Open Access
“Syphilis is a normal thing that children are born with… ”: Understanding Barriers and Facilitators to Maternal and Congenital Syphilis Care in Kampala, Uganda
Introduction: Congenital syphilis (CS) remains a major cause of preventable stillbirths and neonatal deaths globally. This qualitative study explored perceptions and experiences of mothers, partners, providers, and policymakers regarding the barriers and facilitators to implementing antenatal and newborn syphilis testing and treatment in Kampala, Uganda. Methods: We conducted 15 in-depth interviews, four focus group discussions, and 16 key informant interviews between March and May 2022 with pregnant and postnatal women, male partners, health workers, traditional birth attendants, and Ministry of Health policymakers. Data were analyzed using the Consolidated Framework for Implementation Research (CFIR) in NVivo 12 and reported following the COREQ checklist. Results: Participants valued syphilis screening and treatment to protect infant health, particularly when they understood the consequences of untreated infection. Facilitators included respectful counselling, phone-based follow-up, and integration of testing into routine antenatal care. Key barriers included fear of painful injections, stigma and disclosure risk, low male-partner involvement, fragmented information systems, limited infant diagnostics, and medication stockouts. Partner notification was hindered by fears of infidelity accusations and relationship conflict. Notably, caregivers frequently refused treatment for asymptomatic infants due to misconceptions that only visibly ill children required care. Facility opportunities to strengthen the syphilis care cascade were identified such patient tracing systems and strengthened supply chains. Conclusions: Addressing CS requires community education, non-parenteral treatment alternatives, and affordable confirmatory neonatal testing. Stronger supply chains, integrated maternal-infant-partner care pathways, better-equipped health workers, male-engagement strategies, and consistent follow-up are needed to accelerate elimination of mother-to-child syphilis transmission in Uganda and similar settings. What is already known on this topic: Congenital syphilis (CS) remains a major cause of preventable stillbirths and neonatal deaths, but the views of people delivering and receiving syphilis care in Uganda are poorly understood. What this study adds: Participants valued CS screening and treatment to protect infants, and facilitators included respectful counselling, phone follow-up and routine antenatal integration. Barriers included fear of injections, stigma, low male-partner involvement, weak information systems, stockouts of supplies, lack of CS confirmatory tests and caregivers refusing prolonged intravenous treatment for infants without symptoms. How this study might affect research, practice or policy: Programmes need community education, male engagement, patient tracing, stronger supply chains and integrated maternal-infant-partner care. Research should prioritise non-injectable, shorter duration infant treatments and affordable neonatal confirmatory testing. Summary: This qualitative study in Kampala, Uganda explored barriers and facilitators to maternal and congenital syphilis care. Key barriers included fear of painful injections, stigma, low male-partner involvement, and treatment refusal for asymptomatic infants. Facilitators included respectful counselling, phone follow-up, and integrating syphilis testing into routine antenatal care.
Open Access“Syphilis is a normal thing that children are born with… ”: Understanding Barriers and Facilitators to Maternal and Congenital Syphilis Care in Kampala, Uganda
Introduction: Congenital syphilis (CS) remains a major cause of preventable stillbirths and neonatal deaths globally. This qualitative study explored perceptions and experiences of mothers, partners, providers, and policymakers regarding the barriers and facilitators to implementing antenatal and newborn syphilis testing and treatment in Kampala, Uganda. Methods: We conducted 15 in-depth interviews, four focus group discussions, and 16 key informant interviews between March and May 2022 with pregnant and postnatal women, male partners, health workers, traditional birth attendants, and Ministry of Health policymakers. Data were analyzed using the Consolidated Framework for Implementation Research (CFIR) in NVivo 12 and reported following the COREQ checklist. Results: Participants valued syphilis screening and treatment to protect infant health, particularly when they understood the consequences of untreated infection. Facilitators included respectful counselling, phone-based follow-up, and integration of testing into routine antenatal care. Key barriers included fear of painful injections, stigma and disclosure risk, low male-partner involvement, fragmented information systems, limited infant diagnostics, and medication stockouts. Partner notification was hindered by fears of infidelity accusations and relationship conflict. Notably, caregivers frequently refused treatment for asymptomatic infants due to misconceptions that only visibly ill children required care. Facility opportunities to strengthen the syphilis care cascade were identified such patient tracing systems and strengthened supply chains. Conclusions: Addressing CS requires community education, non-parenteral treatment alternatives, and affordable confirmatory neonatal testing. Stronger supply chains, integrated maternal-infant-partner care pathways, better-equipped health workers, male-engagement strategies, and consistent follow-up are needed to accelerate elimination of mother-to-child syphilis transmission in Uganda and similar settings. What is already known on this topic: Congenital syphilis (CS) remains a major cause of preventable stillbirths and neonatal deaths, but the views of people delivering and receiving syphilis care in Uganda are poorly understood. What this study adds: Participants valued CS screening and treatment to protect infants, and facilitators included respectful counselling, phone follow-up and routine antenatal integration. Barriers included fear of injections, stigma, low male-partner involvement, weak information systems, stockouts of supplies, lack of CS confirmatory tests and caregivers refusing prolonged intravenous treatment for infants without symptoms. How this study might affect research, practice or policy: Programmes need community education, male engagement, patient tracing, stronger supply chains and integrated maternal-infant-partner care. Research should prioritise non-injectable, shorter duration infant treatments and affordable neonatal confirmatory testing. Summary: This qualitative study in Kampala, Uganda explored barriers and facilitators to maternal and congenital syphilis care. Key barriers included fear of painful injections, stigma, low male-partner involvement, and treatment refusal for asymptomatic infants. Facilitators included respectful counselling, phone follow-up, and integrating syphilis testing into routine antenatal care.
- Open Access
Improving Antenatal Syphilis Screening and Treatment Coverage in Public Health Facilities in Kampala, Uganda: A Pre-Implementation and Implementation-Phase Study
Introduction: Congenital syphilis (CS) remains a major cause of preventable adverse pregnancy outcomes globally, driven by poor antenatal care (ANC) quality, health-system barriers, and untreated maternal infection. In Uganda, syphilis screening and treatment coverage remains below national targets. We evaluated service-delivery impact of a multi-component syphilis testing and treatment intervention implemented across four public health facilities in Kampala, Uganda. Methods: Guided by the Consolidated Framework for Implementation Research (CFIR), the intervention introduced same-day dual HIV/syphilis antibody testing, on-site treatment, and partner notification at three ANC facilities with women with serological evidence of syphilis or unknown syphilis status and infant follow-up at a tertiary referral hospital. Facility register data were compared between a pre-implementation period (January-December 2020) and the implementation period (June 2021-July 2022) using a modified Poisson regression model adjusting for site. Results: Syphilis screening among women attending their first ANC visit increased from 55.2% to 88.3% (+33.6%; 95% CI 21.0-46.3; p<0.001); same-day treatment among those testing positive increased from 74% to 100% (difference 26.1; 95% CI 22.4-29.9; p<0.001). Partner testing increased nearly five-fold, from 11.8% to 62% (difference 51.9; 95% CI 46.8-57.0; p<0.001); 23.6% of tested partners were positive. Among the high-risk women, 62% tested positive for syphilis, nearly fifteen-fold higher than the general ANC population, and up to 46% of their infants met criteria for confirmed or possible CS; 41% of whom completed intravenous treatment. Conclusions: A same-day rapid test-and-treat intervention substantially improved maternal syphilis screening and treatment coverage, even during the COVID-19 pandemic, but partner and infant treatment completion remained major gaps in the care cascade. Structural interventions, including integrated maternal-infant care pathways and targeting of high-risk mothers along with their male partners, are needed to close these gaps and advance progress toward the elimination of mother-to-child transmission of syphilis. What is already known on this topic: Congenital syphilis (CS) is a major, preventable cause of stillbirth, neonatal death and adverse pregnancy outcomes, driven by missed or late screening, delayed treatment and untreated maternal infection. In Uganda, antenatal syphilis screening and treatment fall below national targets, and it is unclear whether health-system interventions can close these gaps in routine public facilities. What this study adds: A multi-component intervention (same-day dual HIV/syphilis testing, on-site treatment and partner notification) substantially increased first-visit screening in Kampala public facilities, and all women who tested positive were treated the same day. Partner testing rose several-fold, and many tested partners were positive, revealing a large untreated reservoir. High-risk women had much higher syphilis positivity than the general antenatal population. Nearly half of their infants met criteria for confirmed or possible CS, yet fewer than half of these infants completed intravenous treatment. How this study might affect research, practice or policy: Same-day test-and-treat is feasible in routine ANC and could be scaled nationally, with targeting of high-risk women and their male partners. Partner and infant treatment completion are the weakest points in the care cascade, so integrated maternal-infant care pathways are needed to advance elimination of mother-to-child transmission. Future research should test strategies to improve partner treatment and infant follow-up and assess the effect on CS incidence and cost-effectiveness.
Open AccessImproving Antenatal Syphilis Screening and Treatment Coverage in Public Health Facilities in Kampala, Uganda: A Pre-Implementation and Implementation-Phase Study
Introduction: Congenital syphilis (CS) remains a major cause of preventable adverse pregnancy outcomes globally, driven by poor antenatal care (ANC) quality, health-system barriers, and untreated maternal infection. In Uganda, syphilis screening and treatment coverage remains below national targets. We evaluated service-delivery impact of a multi-component syphilis testing and treatment intervention implemented across four public health facilities in Kampala, Uganda. Methods: Guided by the Consolidated Framework for Implementation Research (CFIR), the intervention introduced same-day dual HIV/syphilis antibody testing, on-site treatment, and partner notification at three ANC facilities with women with serological evidence of syphilis or unknown syphilis status and infant follow-up at a tertiary referral hospital. Facility register data were compared between a pre-implementation period (January-December 2020) and the implementation period (June 2021-July 2022) using a modified Poisson regression model adjusting for site. Results: Syphilis screening among women attending their first ANC visit increased from 55.2% to 88.3% (+33.6%; 95% CI 21.0-46.3; p<0.001); same-day treatment among those testing positive increased from 74% to 100% (difference 26.1; 95% CI 22.4-29.9; p<0.001). Partner testing increased nearly five-fold, from 11.8% to 62% (difference 51.9; 95% CI 46.8-57.0; p<0.001); 23.6% of tested partners were positive. Among the high-risk women, 62% tested positive for syphilis, nearly fifteen-fold higher than the general ANC population, and up to 46% of their infants met criteria for confirmed or possible CS; 41% of whom completed intravenous treatment. Conclusions: A same-day rapid test-and-treat intervention substantially improved maternal syphilis screening and treatment coverage, even during the COVID-19 pandemic, but partner and infant treatment completion remained major gaps in the care cascade. Structural interventions, including integrated maternal-infant care pathways and targeting of high-risk mothers along with their male partners, are needed to close these gaps and advance progress toward the elimination of mother-to-child transmission of syphilis. What is already known on this topic: Congenital syphilis (CS) is a major, preventable cause of stillbirth, neonatal death and adverse pregnancy outcomes, driven by missed or late screening, delayed treatment and untreated maternal infection. In Uganda, antenatal syphilis screening and treatment fall below national targets, and it is unclear whether health-system interventions can close these gaps in routine public facilities. What this study adds: A multi-component intervention (same-day dual HIV/syphilis testing, on-site treatment and partner notification) substantially increased first-visit screening in Kampala public facilities, and all women who tested positive were treated the same day. Partner testing rose several-fold, and many tested partners were positive, revealing a large untreated reservoir. High-risk women had much higher syphilis positivity than the general antenatal population. Nearly half of their infants met criteria for confirmed or possible CS, yet fewer than half of these infants completed intravenous treatment. How this study might affect research, practice or policy: Same-day test-and-treat is feasible in routine ANC and could be scaled nationally, with targeting of high-risk women and their male partners. Partner and infant treatment completion are the weakest points in the care cascade, so integrated maternal-infant care pathways are needed to advance elimination of mother-to-child transmission. Future research should test strategies to improve partner treatment and infant follow-up and assess the effect on CS incidence and cost-effectiveness.
- Open Access
- 15 October 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0347364
Client, health care provider, and policymaker perspectives on point-of-care/near-point-of-care testing for sexually transmitted infections in community pharmacies in Uganda
Introduction: Point-of-care or near-point-of-care (POC/near-POC) tests for sexually transmitted infections (STIs) are often unavailable and unaffordable in low-resource settings, despite the World Health Organization’s (WHO) recommendation that such testing be offered, leading to empiric treatment. Private community pharmacies (CPs) are often the first point of contact for people with symptoms of STIs, where pharmacists dispense treatment without diagnostic testing or prescriptions. This study evaluated clients,’ providers,’ and policymakers’ perspectives on POC/near-POC STI testing in community pharmacies for targeted management. Methods: Between June and September 2022, we nested a qualitative study into a prospective cohort of clients seeking both STI and non-STI treatments in community pharmacies in Kampala and Wakiso districts in Uganda. They were tested for HIV, syphilis, trichomonas, chlamydia, and gonorrhea using POC/near-POC tests. A purposive sample of 50 participants consented to participate in in-depth and key informant interviews. Data were analyzed thematically using NVivo version 14 with an inductive approach, with results reported according to the Consolidated Criteria for Reporting Qualitative Research (COREQ). Results: Clients (n = 35), health care providers (n = 9), and policymakers (n = 6) described the benefits of POC/near-POC tests for HIV/STIs at community pharmacies, citing affordability, accessibility, and convenience. Participants noted that such testing could promote behavioral change, shorten turnaround time for results, speed access to treatment relative to conventional laboratory methods, and support sustainable antimicrobial resistance control. Reported barriers included limited awareness among clients and health workers, inadequate privacy and space, long waiting times, unclear self-sample collection instructions, stigma around HIV testing, and reluctance to test for non-HIV STIs. Participants recommended raising STI awareness, offering clearer explanations of test results, expanding test access, reducing stigma, provider training, and ensuring a sustainable supply chain for testing kits. Conclusions: POC/near-POC testing for HIV/STIs was highly acceptable to both pharmacy clients and providers in this study. Integrating such testing into community pharmacy settings could strengthen national HIV/STI management programs, and addressing the identified barriers could improve access to HIV/STI diagnostics and strengthen linkage to care.
- 15 October 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (10) , e0347364
Open AccessClient, health care provider, and policymaker perspectives on point-of-care/near-point-of-care testing for sexually transmitted infections in community pharmacies in Uganda
Introduction: Point-of-care or near-point-of-care (POC/near-POC) tests for sexually transmitted infections (STIs) are often unavailable and unaffordable in low-resource settings, despite the World Health Organization’s (WHO) recommendation that such testing be offered, leading to empiric treatment. Private community pharmacies (CPs) are often the first point of contact for people with symptoms of STIs, where pharmacists dispense treatment without diagnostic testing or prescriptions. This study evaluated clients,’ providers,’ and policymakers’ perspectives on POC/near-POC STI testing in community pharmacies for targeted management. Methods: Between June and September 2022, we nested a qualitative study into a prospective cohort of clients seeking both STI and non-STI treatments in community pharmacies in Kampala and Wakiso districts in Uganda. They were tested for HIV, syphilis, trichomonas, chlamydia, and gonorrhea using POC/near-POC tests. A purposive sample of 50 participants consented to participate in in-depth and key informant interviews. Data were analyzed thematically using NVivo version 14 with an inductive approach, with results reported according to the Consolidated Criteria for Reporting Qualitative Research (COREQ). Results: Clients (n = 35), health care providers (n = 9), and policymakers (n = 6) described the benefits of POC/near-POC tests for HIV/STIs at community pharmacies, citing affordability, accessibility, and convenience. Participants noted that such testing could promote behavioral change, shorten turnaround time for results, speed access to treatment relative to conventional laboratory methods, and support sustainable antimicrobial resistance control. Reported barriers included limited awareness among clients and health workers, inadequate privacy and space, long waiting times, unclear self-sample collection instructions, stigma around HIV testing, and reluctance to test for non-HIV STIs. Participants recommended raising STI awareness, offering clearer explanations of test results, expanding test access, reducing stigma, provider training, and ensuring a sustainable supply chain for testing kits. Conclusions: POC/near-POC testing for HIV/STIs was highly acceptable to both pharmacy clients and providers in this study. Integrating such testing into community pharmacy settings could strengthen national HIV/STI management programs, and addressing the identified barriers could improve access to HIV/STI diagnostics and strengthen linkage to care.
- Open Access
- 11 July 2026
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
“We Have Come to Work as Maids, not Sex Slaves”: young women domestic workers and sexual violence in Uganda
Young women with limited education who migrate from rural to urban areas in Uganda for household domestic work face multiple, intersecting vulnerabilities
- 11 July 2026
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Open Access“We Have Come to Work as Maids, not Sex Slaves”: young women domestic workers and sexual violence in Uganda
Young women with limited education who migrate from rural to urban areas in Uganda for household domestic work face multiple, intersecting vulnerabilities
- Open Access
- 8 July 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
Pharyngeal Gonorrhea in Ugandan Men With Urogenital Gonorrhea: Differences in Antimicrobial Resistance and Strain Types Between Anatomical Sites
Background: Pharyngeal Neisseria gonorrhoeae (phNG) infections are difficult to treat and contribute to antimicrobial resistance (AMR) in NG, but studies on phNG and differences with urogenital NG (uNG) are limited. Methods: Participants with urethral discharge syndrome were recruited at health clinics in Kampala, Uganda, between July 2020 and August 2023. Penile-meatal and pharyngeal swabs were cultured for NG and tested by nucleic acid amplification test (NAAT) for NG, Chlamydia trachomatis, and Mycoplasma genitalium. Paired uNG and phNG isolates were subjected to susceptibility testing and whole genome sequencing (WGS). Demographic and behavioral data were analyzed for correlates of uNG and phNG. Results: The participants’ (n = 411) median [IQR] age was 25 [22, 32] years; 16.7% (67/401) were living with HIV. By NAAT and/or culture, 273 (66.4%) participants were positive for uNG and 29 (7.1%) for phNG. Of those with uNG, 10.6% (29/273) were NAAT-positive for phNG; 69.0% (20/29) were culture-positive for phNG. All (n = 40) NG isolates were susceptible to cefixime and ceftriaxone and displayed intermediate resistance/resistance to ciprofloxacin, penicillin, and tetracycline; 8 displayed high-level azithromycin resistance. WGS showed that 52.6% (10/19) of participants had different strains at urethral and pharyngeal sites. Having different strains at 2 anatomical sites was more common in men self-reporting transactional sex (P = .019). Conclusions: phNG is common in Ugandan men with uNG, both displaying high rates of AMR. Different strains at the 2 anatomical sites were common, supporting the need for pharyngeal testing and phNG susceptibility testing as the pharynx is a critical site for AMR emergence.
- 8 July 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
Open AccessPharyngeal Gonorrhea in Ugandan Men With Urogenital Gonorrhea: Differences in Antimicrobial Resistance and Strain Types Between Anatomical Sites
Background: Pharyngeal Neisseria gonorrhoeae (phNG) infections are difficult to treat and contribute to antimicrobial resistance (AMR) in NG, but studies on phNG and differences with urogenital NG (uNG) are limited. Methods: Participants with urethral discharge syndrome were recruited at health clinics in Kampala, Uganda, between July 2020 and August 2023. Penile-meatal and pharyngeal swabs were cultured for NG and tested by nucleic acid amplification test (NAAT) for NG, Chlamydia trachomatis, and Mycoplasma genitalium. Paired uNG and phNG isolates were subjected to susceptibility testing and whole genome sequencing (WGS). Demographic and behavioral data were analyzed for correlates of uNG and phNG. Results: The participants’ (n = 411) median [IQR] age was 25 [22, 32] years; 16.7% (67/401) were living with HIV. By NAAT and/or culture, 273 (66.4%) participants were positive for uNG and 29 (7.1%) for phNG. Of those with uNG, 10.6% (29/273) were NAAT-positive for phNG; 69.0% (20/29) were culture-positive for phNG. All (n = 40) NG isolates were susceptible to cefixime and ceftriaxone and displayed intermediate resistance/resistance to ciprofloxacin, penicillin, and tetracycline; 8 displayed high-level azithromycin resistance. WGS showed that 52.6% (10/19) of participants had different strains at urethral and pharyngeal sites. Having different strains at 2 anatomical sites was more common in men self-reporting transactional sex (P = .019). Conclusions: phNG is common in Ugandan men with uNG, both displaying high rates of AMR. Different strains at the 2 anatomical sites were common, supporting the need for pharyngeal testing and phNG susceptibility testing as the pharynx is a critical site for AMR emergence.
- Open Access
- 18 June 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Prevalence of HIV and associated sociobehavioral factors among men with urethral discharge syndrome attending public health facilities in Kampala, Uganda
Epidemiological data on HIV infection in male urethral discharge syndrome (UDS) in Africa are limited. We describe the prevalence of HIV and associated demographic and sociobehavioral factors among men with UDS in selected public clinics in Kampala, Uganda. Within a cross-sectional study of men seeking care for UDS from October 2019 to July 2022, we performed interviewer-administered demographic and sociobehavioral questionnaires. Point-of-care (POC) rapid sequential algorithmic HIV testing was conducted. Bivariate and adjusted multivariable log-binomial regression analyses were performed to determine factors associated with HIV. Of 450 male participants, 441(98%) were included in this analysis; 9 declined HIV testing. Median (IQR) age was 24 (22-32) years, 87% (n = 384) reported a previous HIV test. Overall, 18.4% (n = 81) were people living with HIV (PLWHIV). Of these, 86.4% and 13.6% were aged ≥ 25 and < 25 years, respectively. Overall, 8.6% (n = 7) were newly diagnosed with HIV; of those, 42.9% (n = 3) were aged < 25 years. While 94% (70/74) with known HIV reported antiretroviral therapy (ART) use, 52.9% (n = 37) had suppressed viral loads by self-report. Five of the 441 participants (1.1%) reported 'always' condom use, 45.4% (n = 200) reported transactional sex, 59.6% (n = 263) ≥ 2 sexual partners in the past six months; 46.7% (n = 206) had notified their partners of UDS symptoms. Multivariable analysis demonstrated significant associations between HIV and older age ≥ 25 years (aPR,6.35; 95% C.I., 3.44-11.75; P < 0.001), and hazardous alcohol use (aPR,1.62; 95% C.I., 1.03-2.54; P = 0.038). Almost one in five men presenting with UDS were PLWHIV, with just over half of those on ART reporting viral suppression. Older age and hazardous alcohol use were associated with HIV. Men with UDS represent a key population where HIV diagnosis, prevention, and ART adherence interventions may have a significant impact.
- 18 June 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessPrevalence of HIV and associated sociobehavioral factors among men with urethral discharge syndrome attending public health facilities in Kampala, Uganda
Epidemiological data on HIV infection in male urethral discharge syndrome (UDS) in Africa are limited. We describe the prevalence of HIV and associated demographic and sociobehavioral factors among men with UDS in selected public clinics in Kampala, Uganda. Within a cross-sectional study of men seeking care for UDS from October 2019 to July 2022, we performed interviewer-administered demographic and sociobehavioral questionnaires. Point-of-care (POC) rapid sequential algorithmic HIV testing was conducted. Bivariate and adjusted multivariable log-binomial regression analyses were performed to determine factors associated with HIV. Of 450 male participants, 441(98%) were included in this analysis; 9 declined HIV testing. Median (IQR) age was 24 (22-32) years, 87% (n = 384) reported a previous HIV test. Overall, 18.4% (n = 81) were people living with HIV (PLWHIV). Of these, 86.4% and 13.6% were aged ≥ 25 and < 25 years, respectively. Overall, 8.6% (n = 7) were newly diagnosed with HIV; of those, 42.9% (n = 3) were aged < 25 years. While 94% (70/74) with known HIV reported antiretroviral therapy (ART) use, 52.9% (n = 37) had suppressed viral loads by self-report. Five of the 441 participants (1.1%) reported 'always' condom use, 45.4% (n = 200) reported transactional sex, 59.6% (n = 263) ≥ 2 sexual partners in the past six months; 46.7% (n = 206) had notified their partners of UDS symptoms. Multivariable analysis demonstrated significant associations between HIV and older age ≥ 25 years (aPR,6.35; 95% C.I., 3.44-11.75; P < 0.001), and hazardous alcohol use (aPR,1.62; 95% C.I., 1.03-2.54; P = 0.038). Almost one in five men presenting with UDS were PLWHIV, with just over half of those on ART reporting viral suppression. Older age and hazardous alcohol use were associated with HIV. Men with UDS represent a key population where HIV diagnosis, prevention, and ART adherence interventions may have a significant impact.
- Open Access
Client and Health Care Provider Perspectives on Point-of-Care Testing for Sexually Transmitted Infections in Community Pharmacies in Uganda
Introduction: The World Health Organization (WHO) recommends testing for sexually transmitted infections (STIs), but laboratory-based and rapid or point-of-care (POC) testing are often unavailable and unaffordable, especially in low-resource settings, leading to empiric (usually antibiotic) treatment. Community pharmacies (CPs) are often the first point of contact for persons with symptoms of STIs, where pharmacists dispense treatment without diagnostic testing or prescriptions. This study evaluated clients, providers, and policymakers’ perspectives on POC testing for STIs in CPs for targeted treatment. Methods: We nested a qualitative study into a study of participants seeking both STI and non-STI treatments in CPs. They were tested for HIV, syphilis, trichomonas, chlamydia, and gonorrhea using both rapid POC tests and a central reference lab. A purposive sample of 50 participants from September 2020 to June 2022 consented to participate in in-depth and key informant interviews. Data were analyzed thematically using an inductive approach. Results: Clients (n=35), health care providers (n=9), and policy makers (n=6) highlighted the benefits of POC tests for HIV and STIs at CPs, including affordability, accessibility, and ensuring convenience. The impact of POC testing for STI diagnosis and treatment was promoting behavioral change, rapid results turnaround time, leading to faster treatment access compared to conventional laboratory methods, and supporting sustainable antimicrobial resistance (AMR) control. Barriers to POC testing included a lack of awareness among clients and health workers, inadequate privacy and space, long wait times, unclear self-sample collection instructions, stigma around HIV testing, and reluctance to test for STIs beyond HIV. To address these, participant recommendations included raising STI awareness, providing more explanation of test results, increasing test access, addressing stigma, provider training, and ensuring a sustainable supply chain for testing kits. Conclusions: POC testing for STIs and HIV in CP settings was found to be highly acceptable to both pharmacy clients and providers. Integrating POC testing in CPs could be beneficial for national STI management programs. If the existing barriers are addressed, POC tests could improve accessibility to STI diagnostics and facilitate better linkage to care.
Open AccessClient and Health Care Provider Perspectives on Point-of-Care Testing for Sexually Transmitted Infections in Community Pharmacies in Uganda
Introduction: The World Health Organization (WHO) recommends testing for sexually transmitted infections (STIs), but laboratory-based and rapid or point-of-care (POC) testing are often unavailable and unaffordable, especially in low-resource settings, leading to empiric (usually antibiotic) treatment. Community pharmacies (CPs) are often the first point of contact for persons with symptoms of STIs, where pharmacists dispense treatment without diagnostic testing or prescriptions. This study evaluated clients, providers, and policymakers’ perspectives on POC testing for STIs in CPs for targeted treatment. Methods: We nested a qualitative study into a study of participants seeking both STI and non-STI treatments in CPs. They were tested for HIV, syphilis, trichomonas, chlamydia, and gonorrhea using both rapid POC tests and a central reference lab. A purposive sample of 50 participants from September 2020 to June 2022 consented to participate in in-depth and key informant interviews. Data were analyzed thematically using an inductive approach. Results: Clients (n=35), health care providers (n=9), and policy makers (n=6) highlighted the benefits of POC tests for HIV and STIs at CPs, including affordability, accessibility, and ensuring convenience. The impact of POC testing for STI diagnosis and treatment was promoting behavioral change, rapid results turnaround time, leading to faster treatment access compared to conventional laboratory methods, and supporting sustainable antimicrobial resistance (AMR) control. Barriers to POC testing included a lack of awareness among clients and health workers, inadequate privacy and space, long wait times, unclear self-sample collection instructions, stigma around HIV testing, and reluctance to test for STIs beyond HIV. To address these, participant recommendations included raising STI awareness, providing more explanation of test results, increasing test access, addressing stigma, provider training, and ensuring a sustainable supply chain for testing kits. Conclusions: POC testing for STIs and HIV in CP settings was found to be highly acceptable to both pharmacy clients and providers. Integrating POC testing in CPs could be beneficial for national STI management programs. If the existing barriers are addressed, POC tests could improve accessibility to STI diagnostics and facilitate better linkage to care.
- Open Access
- 1 April 2026
- Published by BMJ in BMJ Public Health
- Vol. 4 (2) , e003618
Prevalence and correlates of prevalent sexually transmitted infections among young women employed as domestic workers in Central Uganda: a community-based cross-sectional study
Introduction: Little is known about the burden of sexually transmitted infections (STIs) among adolescent girls and young women (AGYW) employed as domestic workers in Ugandan households. Methods: We conducted a community-based cross-sectional study from November 2023 to March 2024 to determine the prevalence and correlates of STIs among Ugandan AGYW aged 14–24 in the Kampala Metropolitan Area. Self-collected vaginal swabs were tested for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) using GeneXpert. HIV and syphilis testing were performed using the Bioline HIV/syphilis Duo test. Correlates of STI prevalence were determined using modified Poisson regression. Results: Among 262 AGYW, median age was 20 years (IQR 18–23) and 87 (33%) had an STI: CT (27.5%), syphilis (5.7%), HIV (4.6%) and NG (1.5%). Overall, 14.9% had >1 STI. Of 12 AGYW with HIV, 3 (25%) were newly diagnosed and 6/9 had detectable viral loads (≥1000 copies/mL). In the prior 12 months, 126 (48%) had received syndromic STI treatment, but only 35 (28%) notified their partners. Additionally, 102 (39%) had used emergency contraception and 54% believed it was protective against STIs, including HIV. Factors associated with STI prevalence included non-cash compensation for domestic work (adjusted prevalence ratio (aPR) 2.26; 95% CI 1.04 to 4.92; p=0.040), lower educational attainment (aPR 1.73; 95% CI 1.16 to 2.57; p=0.007), alcohol consumption in the past 6 months (aPR 1.72; 95% CI 1.12 to 2.64; p=0.013) and transactional sex during the past 6 months (aPR 1.43; 95% CI 1.01 to 2.04; p=0.045). Conversely, self-reported sexual abuse was negatively associated with STIs (aPR 0.48; 95% CI 0.28 to 0.83; p=0.008). Conclusion: The high prevalence of undiagnosed STIs and unsuppressed HIV among AGYW domestic workers in Central Uganda highlights the urgent need to increase STI/HIV prevention, testing and treatment coverage for these underserved and vulnerable young women. Targeted interventions are needed to mitigate STI/HIV acquisition in this population.
- 1 April 2026
- Published by BMJ in BMJ Public Health
- Vol. 4 (2) , e003618
Open AccessPrevalence and correlates of prevalent sexually transmitted infections among young women employed as domestic workers in Central Uganda: a community-based cross-sectional study
Introduction: Little is known about the burden of sexually transmitted infections (STIs) among adolescent girls and young women (AGYW) employed as domestic workers in Ugandan households. Methods: We conducted a community-based cross-sectional study from November 2023 to March 2024 to determine the prevalence and correlates of STIs among Ugandan AGYW aged 14–24 in the Kampala Metropolitan Area. Self-collected vaginal swabs were tested for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) using GeneXpert. HIV and syphilis testing were performed using the Bioline HIV/syphilis Duo test. Correlates of STI prevalence were determined using modified Poisson regression. Results: Among 262 AGYW, median age was 20 years (IQR 18–23) and 87 (33%) had an STI: CT (27.5%), syphilis (5.7%), HIV (4.6%) and NG (1.5%). Overall, 14.9% had >1 STI. Of 12 AGYW with HIV, 3 (25%) were newly diagnosed and 6/9 had detectable viral loads (≥1000 copies/mL). In the prior 12 months, 126 (48%) had received syndromic STI treatment, but only 35 (28%) notified their partners. Additionally, 102 (39%) had used emergency contraception and 54% believed it was protective against STIs, including HIV. Factors associated with STI prevalence included non-cash compensation for domestic work (adjusted prevalence ratio (aPR) 2.26; 95% CI 1.04 to 4.92; p=0.040), lower educational attainment (aPR 1.73; 95% CI 1.16 to 2.57; p=0.007), alcohol consumption in the past 6 months (aPR 1.72; 95% CI 1.12 to 2.64; p=0.013) and transactional sex during the past 6 months (aPR 1.43; 95% CI 1.01 to 2.04; p=0.045). Conversely, self-reported sexual abuse was negatively associated with STIs (aPR 0.48; 95% CI 0.28 to 0.83; p=0.008). Conclusion: The high prevalence of undiagnosed STIs and unsuppressed HIV among AGYW domestic workers in Central Uganda highlights the urgent need to increase STI/HIV prevention, testing and treatment coverage for these underserved and vulnerable young women. Targeted interventions are needed to mitigate STI/HIV acquisition in this population.
- Open Access
Associations with Prevalent Sexually Transmitted Infection Prevalence among Young Women Domestic Workers in Central Uganda
Objective: Our study aimed to determine the prevalence and correlates of sexually transmitted infections (STIs) among adolescent girls and young women (AGYW) employed as household domestic workers in Kampala, Uganda. Methods: Ugandan AGYW aged 14-24 participated in a community-based cross-sectional study in the Kampala Metropolitan Area from November 2023 to March 2024. Self-collected vaginal swabs were tested for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) using GeneXpert™. Testing for HIV and syphilis was performed using the Bioline™ HIV/syphilis Duo test. Correlates of STI prevalence were determined using modified Poisson regression. Results: Of 262 AGYW enrolled, the median age was 20 years (IQR 18-23), and 87 (33%) had an STI: Chlamydia trachomatis (27.5%), syphilis (5.7%), HIV (4.6%), and Neisseria gonorrhoea (1.5%). Overall, 14.9% had >1 STI. Of 12 AGYW with HIV, three (25%) were newly diagnosed, and 6/9 had detectable viral loads (≥1000 copies/ml). In the prior 12 months, 126 (48%) had received syndromic STI treatment, but only 35 (28%) notified their partners. Additionally, 102 (39%) had used emergency contraception, with 54% believing it was protective against STIs, including HIV. Factors associated with STI prevalence included receipt of non-cash (instead of salary) remuneration for domestic work (adjusted prevalence ratio [aPR] 2.26; 95% CI:1.04-4.92; P=0.040), lower education attainment (aPR 1.73; 95% CI: 1.16-2.57; P=0.007), alcohol consumption in past six months (aPR 1.72; 95% CI: 1.12-2.64; P=0.013) and transactional sex during the past six months (aPR 1.43; 95% CI: 1.01-2.04; P=0.045). Conversely, self-reported sexual abuse was negatively associated with STIs (aPR 0.48; 95% CI: 0.28-0.83; P=0.008). Conclusion: The high prevalence of undiagnosed STIs and unsuppressed HIV among AGYW domestic workers in Kampala highlights the urgent need to increase HIV/STI prevention, testing and treatment coverage for these underserved and vulnerable young women. Targeted interventions are needed to mitigate STI/HIV acquisition in this population. What is already known on this topic - summarise the state of scientific knowledge on this subject before you did your study, and why this study needed to be done.: Adolescent girls and young women (AGYW) in Uganda who are out of school and employed in household domestic work are a highly vulnerable population, often migrating from rural communities to cities with consequent social isolation, and are subject to unequal power dynamics with employers. This puts them at risk of intergenerational and transactional sex. The prevalence of STIs and HIV, and the associated socio-behavioural factors, have been poorly studied in this demographic, limiting the development of interventions for this group. What this study adds - summarise what we now know as a result of this study that we did not know before.: This cross-sectional study, which estimated STI and HIV prevalence among young females employed in household domestic work, found that one-third of AGYW domestic workers were diagnosed with at least one STI. The findings reveal a high burden of STIs and HIV, with many experiencing co-infections. Contributing factors such as poor working conditions, limited educational attainment and prevalent sexual behaviours associated with STIs– including transactional sex, sexual abuse, alcohol use, and inconsistent condom use– exacerbate their vulnerability. How this study might affect research, practice, or policy - summarise the implications of this study.: This research provides insights into STI and HIV risks for vulnerable AGYW employed in domestic work. It highlights the need for tailored HIV and STI interventions that focus on increased awareness, economic and educational empowerment, improved working conditions, socio-behavioural changes, legal redress, as well as expanded access to STI/HIV testing and treatment services for this hard-to-reach population.
Open AccessAssociations with Prevalent Sexually Transmitted Infection Prevalence among Young Women Domestic Workers in Central Uganda
Objective: Our study aimed to determine the prevalence and correlates of sexually transmitted infections (STIs) among adolescent girls and young women (AGYW) employed as household domestic workers in Kampala, Uganda. Methods: Ugandan AGYW aged 14-24 participated in a community-based cross-sectional study in the Kampala Metropolitan Area from November 2023 to March 2024. Self-collected vaginal swabs were tested for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) using GeneXpert™. Testing for HIV and syphilis was performed using the Bioline™ HIV/syphilis Duo test. Correlates of STI prevalence were determined using modified Poisson regression. Results: Of 262 AGYW enrolled, the median age was 20 years (IQR 18-23), and 87 (33%) had an STI: Chlamydia trachomatis (27.5%), syphilis (5.7%), HIV (4.6%), and Neisseria gonorrhoea (1.5%). Overall, 14.9% had >1 STI. Of 12 AGYW with HIV, three (25%) were newly diagnosed, and 6/9 had detectable viral loads (≥1000 copies/ml). In the prior 12 months, 126 (48%) had received syndromic STI treatment, but only 35 (28%) notified their partners. Additionally, 102 (39%) had used emergency contraception, with 54% believing it was protective against STIs, including HIV. Factors associated with STI prevalence included receipt of non-cash (instead of salary) remuneration for domestic work (adjusted prevalence ratio [aPR] 2.26; 95% CI:1.04-4.92; P=0.040), lower education attainment (aPR 1.73; 95% CI: 1.16-2.57; P=0.007), alcohol consumption in past six months (aPR 1.72; 95% CI: 1.12-2.64; P=0.013) and transactional sex during the past six months (aPR 1.43; 95% CI: 1.01-2.04; P=0.045). Conversely, self-reported sexual abuse was negatively associated with STIs (aPR 0.48; 95% CI: 0.28-0.83; P=0.008). Conclusion: The high prevalence of undiagnosed STIs and unsuppressed HIV among AGYW domestic workers in Kampala highlights the urgent need to increase HIV/STI prevention, testing and treatment coverage for these underserved and vulnerable young women. Targeted interventions are needed to mitigate STI/HIV acquisition in this population. What is already known on this topic - summarise the state of scientific knowledge on this subject before you did your study, and why this study needed to be done.: Adolescent girls and young women (AGYW) in Uganda who are out of school and employed in household domestic work are a highly vulnerable population, often migrating from rural communities to cities with consequent social isolation, and are subject to unequal power dynamics with employers. This puts them at risk of intergenerational and transactional sex. The prevalence of STIs and HIV, and the associated socio-behavioural factors, have been poorly studied in this demographic, limiting the development of interventions for this group. What this study adds - summarise what we now know as a result of this study that we did not know before.: This cross-sectional study, which estimated STI and HIV prevalence among young females employed in household domestic work, found that one-third of AGYW domestic workers were diagnosed with at least one STI. The findings reveal a high burden of STIs and HIV, with many experiencing co-infections. Contributing factors such as poor working conditions, limited educational attainment and prevalent sexual behaviours associated with STIs– including transactional sex, sexual abuse, alcohol use, and inconsistent condom use– exacerbate their vulnerability. How this study might affect research, practice, or policy - summarise the implications of this study.: This research provides insights into STI and HIV risks for vulnerable AGYW employed in domestic work. It highlights the need for tailored HIV and STI interventions that focus on increased awareness, economic and educational empowerment, improved working conditions, socio-behavioural changes, legal redress, as well as expanded access to STI/HIV testing and treatment services for this hard-to-reach population.
- 12 May 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (593)
A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility
A portable magnetofluidic platform integrates nucleic acid purification and PCR to rapidly detect the pathogen causing gonorrhea in clinical samples.
- 12 May 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (593)
A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility
A portable magnetofluidic platform integrates nucleic acid purification and PCR to rapidly detect the pathogen causing gonorrhea in clinical samples.